报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 69.86% | -2.31% | -2.13% | 31/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 71.38% | -0.69% | -1.73% | 28/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 72.64% | -0.01% | 2.61% | 26/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 70.79% | -6.07% | -1.01% | 30/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 71.51% | -5% | -0.51% | 29/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 71.88% | -6.17% | -1.06% | 31/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 72.64% | -5.93% | -3.61% | 26/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 75.37% | -5.09% | 0.12% | 28/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 75.27% | -5.79% | -1.73% | 27/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 76.6% | -4.01% | -0.81% | 26/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 77.23% | -5.63% | -2.75% | 25/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 79.41% | -0.72% | -0.62% | 27/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 79.9% | -1.86% | 0.13% | 28/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 79.8% | -3.68% | -2.49% | 30/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2021-03-31 | 81.84% | 2% | 2.32% | 22/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
2020-12-31 | 79.98% | -1.9% | -1.77% | 28/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
2020-09-30 | 81.42% | 2% | -1.72% | 20/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
2020-06-30 | 82.84% | 2% | 1.61% | 26/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
2019-12-31 | 81.53% | 0.52% | 0.52% | 25/54 | 72.44% | 我武生物 | 95.6% | 行业排名> |
2018-12-31 | 81.11% | 2.63% | 2.63% | 19/54 | 71.54% | 我武生物 | 96.43% | 行业排名> |
2017-12-31 | 79.03% | 2% | 2% | 14/54 | -887.82% | 我武生物 | 96.51% | 行业排名> |